A Research Study of the Effect of Food on Etavopivat in Healthy Participants

Clinical Trial
Study Details
Enrollment
16
Interventions
Description

Participants will receive single dose of oral Etavopivat in each treatment period.

Name
Etavopivat
Type
Drug
Phase
Phase 1
Status
COMPLETED
Study ID #
NCT06433661
Study Type
Interventional
Summary

The purpose of this study is to evaluate the effect of food on the amount of etavopivat in the bloodstream of healthy participants. Participants will take a single oral dose of etavopivat following a high-fat meal (i.e. fed) and on an empty stomach (i.e fasted) on two separate occasions.The study will last up to 50 days (including screening).

Study Overview
Conditions
Healthy Volunteers Sickle Cell Disease, Thalassemia
Contacts and Locations
Locations
Facility

ICON-Salt Lake City
Salt Lake City, Utah 84124
United States

GeoPoint
40.76078, -111.89105